CelLBxHealth PLC Announces Key Boardroom Appointments to Strengthen Leadership

CelLBxHealth PLC (AIM: CLBX, OTCQB: ANPCF), the cancer diagnostics specialist, has unveiled a series of significant boardroom appointments aimed at bolstering its executive leadership and strategic direction. At a board meeting held last month, the company confirmed that Peter Collins will take on the role of Chief Executive Officer, stepping into a leadership position to guide the company’s next phase of growth. Alongside this change, Klaas de Boer, Kim Oreskovic and Benjamin Hart have been appointed as non‑executive directors, bringing additional experience and expertise to the board. These changes are expected to support CelLBxHealth’s ongoing efforts to advance its diagnostic technologies and strengthen corporate governance as it continues to pursue its clinical and commercial objectives. #CelLBxHealth #BoardAppointments #HealthcareLeadership #BiotechNews #SlimScan #GrowthStocks #CANSLIM